Results 11 to 20 of about 34,487 (282)

Antiphospholipid Syndrome

open access: bronzeJournal of Investigative Dermatology, 1993
The antiphospholipid antibodies (aPL), namely, the lupus anticoagulant and the anticardiolipin antibodies, are a family of autoantibodies directed predominantly against negatively charged phospholipids. Many studies have confirmed that patients with these antibodies are prone to repeated episodes of thrombosis, fetal losses, and thrombocytopenia.
Asherson, Ronald A., Cervera, Ricard
openaire   +3 more sources

The antiphospholipid syndrome [PDF]

open access: bronzeJournal of Vascular Surgery, 1997
Walter G. Wolfe
openaire   +3 more sources

The Screening of Antiphospholipid Antibodies in Obstetric Antiphospholipid Syndrome-Like Events: A Regional Perspective

open access: yesGynecology Obstetrics & Reproductive Medicine, 2020
Objective: Obstetric antiphospholipid antibody syndrome is clinically recognized by adverse obstetric outcomes. To determine which antibody level best corresponds to the risk of these clinical outcomes is difficult.
Onder Onen, Fusun Gulizar Varol
doaj   +1 more source

Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy

open access: yesBMC Nephrology, 2020
Background The kidney is a major target in primary antiphospholipid syndrome. Several types of nephropathy have been reported, the most frequent being acute or chronic specific vascular nephropathies and membranous nephropathy.
Maxime Teisseyre   +6 more
doaj   +1 more source

Impact of nitric oxide synthesis modulators on the state of humoral immune system in experimental antiphospholipid syndrome [PDF]

open access: yesPharmacia, 2023
Background: Antiphospholipid syndrome is an autoimmune disease of multiple venous and/or arterial thrombosis and/or pregnancy loss. Oxidative stress only enhances the body’s immune response.
Nataliia Mekhno, Olha Yaremchuk
doaj   +3 more sources

Antiphospholipid syndrome [PDF]

open access: yesBMJ, 2015
这是一系列来自患者的零星文章中的最后一篇,他们的经历为医生提供了生动教程。关于"你的患者在想什么"系列的更多信息,请联系患者编辑Rosamund Snow (rsnow@bmj.com)。
Jallow, Tracy   +2 more
openaire   +4 more sources

Obliterative portal venopathy: A neglected and probably misdiagnosed disease with peculiar etiology in South America

open access: yesJGH Open, Volume 6, Issue 12, Page 904-909, December 2022., 2022
Classically described in the group of non‐cirrhotic portal hypertension, obliterative portal venopathy (OPV) causes are still unknown. Our aim is to describe the characteristics of 43 OPV patients and potential risk factors. Clinically significant portal hypertension was found in 28% of cases. The most frequent indication for liver biopsy was elevation
Vinícius Nunes   +7 more
wiley   +1 more source

Is It Antiphospholipid Syndrome? [PDF]

open access: yesInternational Journal of Rheumatology, 2010
The diagnosis of bacterial endocarditis remains a challenge, as nearly half of cases develop in the absence of preexistent heart disease and known risk factors. Not infrequently, a blunted clinical course at onset can lead to erroneous diagnoses.
Ditto M. C.   +5 more
openaire   +1 more source

Recurrent Cerebral Artery Dissection Associated with Seronegative Antiphospholipid Antibody Syndrome

open access: yesTomography, 2022
Stroke in young patients requires thorough evaluation as they often lack risk factors. Antiphospholipid syndrome can cause arterial thrombosis and pregnancy loss; hence, differential diagnoses should include seronegative antiphospholipid syndrome.
Hee Sue Kim   +3 more
doaj   +1 more source

Aortic valve surgery for aortic regurgitation caused by Libman-Sacks endocarditis in a patient with primary antiphospholipid syndrome: a case report

open access: yesJournal of Cardiothoracic Surgery, 2021
Background Antiphospholipid syndrome is an antibody mediated pro-thrombotic state leading to various arterial and venous thromboses. The syndrome can be either primary or secondary to other autoimmune diseases, commonly systemic lupus erythematosus ...
Yan Le Ho   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy